Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-066398

Chairman and CEO bought 27,000 shares at an average $1.41 ($38,130)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2021-11-19 Purchase +15,000 $1.39 $20,850 10,934,147 D
Niihara Yutaka Chairman and CEO 2021-11-22 Purchase +12,000 $1.44 $17,280 10,946,147 D
Open-market purchases · 27,000 sh · avg $1.41 · $38,130
Loading xslF345X03/doc4.xml…